Projects per year
Organisation profileNano technology is the most popular research and industrial application trend in the 21st century. China has also listed it as a national key development goal. Since 2003, it has been conducting two national nanometer projects for 12 years, combining the strength of industry, academia and research. Establishing many R&D achievements and related nanotechnology platforms, regardless of the amount of funds, products or patents invested, are among the best in the world, especially the development of nanomaterials. However, due to the lack of upstream and downstream integration of nanomedical technology development (technical/clinical and academic/industrial); the scale of the industry and the lack of funds and regulations are not clear, the supervision mechanism is not sound enough, many excellent nano in Taiwan Biomedical technology only stays at the stage of academic research and paper publishing, and cannot be effectively applied to the market. How to let nanotechnology research and development go through the most difficult but also the most valuable last road in the commercialization of biomedical applications. Crossing the Valley of Death is Taiwan’s development of the future biomedical industry, based on international important topic. The successful university has nine colleges, a national medical center and an excellent interdisciplinary academic environment, with basic characteristics research from nanometers, development of standard materials, design of test/treatment systems, prototyping, pre-clinical testing, and translational medicine. The ability to perform early clinical trials can be combined into a complete one-stop nanomedical technology development platform. Therefore, the project plans to establish the Nano Medical Research Center (NCKU_CAN), which combines the R&D and innovation energy of the Dali College, the College of Engineering, the Micro-Nei Center and the Medical College, and promotes off-campus through long-term inter-school and cross-border cooperation. Researchers (Qingda and National Health Institute) and foreign (UCLA and Waterloo Institute for Nanotechnology) joined. In addition to the continuous development of innovative nano materials, we will also integrate nano-research platforms at various stages to enable the implementation of nanomedicine industrialization. We will break away from the framework of academic light development and rebalance research and development (R&D). . Develop a task-oriented model that targets clinical needs to replace the method of developing and then looking for application exports, and to solve this problem through a cross-disciplinary team that is closely integrated with the upstream and downstream. The problem of the gap between the prenatal and biomedical industries in production and learning is too large. In addition, the Center will invite many doctors, scholars and industry representatives from the Mesozoic and the new generation to join in, learn from each other through cross-disciplinary cooperation, inherit the experience of domestic and foreign masters, and cultivate important talents of the future. Therefore, in order to develop nanomedicine technology and promote the development of related industries, integrate the research, teaching, translation and innovation of the relevant units of the school, and promote cooperation and exchange with external and foreign research centers or scholars to give full play to the overall benefits. The school's school-level research center setting and management methods, set up ""National University of Science and Nano Medical Research Center."" In addition to continuing to pursue academic excellence and strengthen international influence, the Nano Medical Research Center hopes to become the locomotive of Taiwan's nanomedicine application development and further address the country's demand for biomedical industrialization. I hope that with the development of high-tech, high-value, knowledge-intensive new industries, we will cultivate Taiwan's outstanding high-end research and development talents and provide a stage for performance, and find a new direction for Taiwan's economic development.
Dive into the research topics where Center of Applied Nanomedicine is active. These topic labels come from the works of this organisation's members. Together they form a unique fingerprint.
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Dive into details
Select a country/territory to view shared publications and projects
A dual nociceptin and mu opioid receptor agonist exhibited robust antinociceptive effect with decreased side effectsHsu, Y. T., Chen, S. R., Chang, Y. C., Chang, H. F., Yeh, T. K., Chuang, J. Y., Loh, H. H., Hsieh, H. P., Ueng, S. H. & Yeh, S. H., 2023 Oct 5, In: European Journal of Medicinal Chemistry. 258, 115608.
Research output: Contribution to journal › Article › peer-review
Development of Furanopyrimidine-Based Orally Active Third-Generation EGFR Inhibitors for the Treatment of Non-Small Cell Lung CancerLi, M. C., Coumar, M. S., Lin, S. Y., Lin, Y. S., Huang, G. L., Chen, C. H., Lien, T. W., Wu, Y. W., Chen, Y. T., Chen, C. P., Huang, Y. C., Yeh, K. C., Yang, C. M., Kalita, B., Pan, S. L., Hsu, T. A., Yeh, T. K., Chen, C. T. & Hsieh, H. P., 2023 Feb 23, In: Journal of Medicinal Chemistry. 66, 4, p. 2566-2588 23 p.
Research output: Contribution to journal › Article › peer-reviewOpen Access